A. M. Hicks, G. Riedlinger, M. C. Willingham, M. A. Alexander-Miller, C. Von Kap-Herr, M. J. Pettenati, A. M. Sanders, H. M. Weir, W. Du, J. Kim, et al., “Transferable anticancer innate immunity in spontaneous regression/complete resistance mice,” Proceedings of the National Academy of Science, USA, Vol. 103, No. 20, pp. 7753–7758, 2006.

has been cited by the following article:

• TITLE: Transfusion of Ipscs-Derived Leukocytes to Kill Cancer

  AUTHORS: Jiang Li, Ying Cui, Guodong Gao, Ti-Fei Yuan

  KEYWORDS: Ipscs, Leukocytes, Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.1 No.1, March 25, 2010

  ABSTRACT: Here we propose that the rejuvenation of leukocytes with iPSC technology in vitro and transfusion of cancer cellresistant white blood cells back to human body provide a prospective therapy for cancer patients.